Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1995
12/20/1995CN1113491A Novel hydroxylamines with hypoglycemic activity
12/20/1995CN1113490A New acronycine analogues, a process for their preparation and pharmaceutical compositions containing them
12/20/1995CN1113487A Method for preparing pharmaceutically active CNS compounds
12/20/1995CN1113485A Process for the production of medicaments containing substituted pyridyl-dihydroxy-heptenonic acid or its salts
12/20/1995CN1113438A Emulsive medicine for curing dam's acyesis and production thereof
12/20/1995CN1113437A A process for preparing a pharmaceutical composition containing benzothiazole compounds
12/20/1995CN1113436A Potentiation of drug response
12/20/1995CN1113435A Preparation of pharmaceutical composition containing novel thiazolidone and oxazolidone
12/20/1995CN1113434A Drug
12/20/1995CN1113433A Antiparasitic medicine
12/19/1995US5476966 Method for depletion of glutathione
12/19/1995US5476954 Condensing hydroxyl protected taxane derivative with oxazolidine derivative, decyclizing in acid medium, reacting butoxycarbonyl or benzoyl radical with amine, deprotecting, isolating, purifying product
12/19/1995US5476950 Aminopyrrolidine compound
12/19/1995US5476932 Selective hydrolysis or deacylating of sugar part of acylcytidine compound
12/19/1995US5476930 Thiophosphorylacetylamino linkage; reacting a thiophosphate compound with a bromoacetylamino compound
12/19/1995US5476876 Di-tert-butylphenol compounds useful as anti-inflammatory agents
12/19/1995US5476875 Catechol derivatives
12/19/1995US5476874 New HIV protease inhibitors
12/19/1995US5476872 1,11-diesters of prostaglandin-F2α having a polar ester group at C-1
12/19/1995US5476870 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics
12/19/1995US5476867 Pharmaceutical compositions
12/19/1995US5476866 Isoxazoles
12/19/1995US5476865 Methods of inhibiting bone loss
12/19/1995US5476862 Activation of Protein C
12/19/1995US5476861 Treating allergic diseases
12/19/1995US5476860 Diaromatic compounds derived from a salicylic unit and their use in human and veterinary medicine and in cosmetics
12/19/1995US5476858 Use of carbostyril to increase somatostatin or for inhibiting decrease of somatostatin to treat diseases related thereto
12/19/1995US5476857 Imidazopyridines
12/19/1995US5476856 Treatment of PAF and histamine-mediated diseases with 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
12/19/1995US5476855 Enzyme inhibitors, their synthesis and methods for use
12/19/1995US5476854 Side effect reduction
12/19/1995US5476853 Agent for use as an anti-irritant
12/19/1995US5476852 Method of topically treating acne vulgaris, hyperkeratotic dermatoses, and photo-aging of the skin
12/19/1995US5476851 Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor protein tyrosine kinase
12/19/1995US5476850 Amino-substituted benzenesulfonylureas and -thioureas and their use as pharmaceuticals
12/19/1995US5476849 Methods for glycosylation inhibition using amino-benzoic acids and derivatives
12/19/1995US5476847 Treating cardiovascular, gastrointestinal, urogenital disorders
12/19/1995US5476846 Administering anti-thrombotic and anti-asthmatic agent
12/19/1995US5476844 Gamma inulin compositions
12/19/1995US5476843 Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic
12/19/1995US5476842 Administering conjugate of cytotoxic phenolic compounds and mono- or disaccharides; damages cancer cells
12/19/1995US5476841 Peptide
12/19/1995US5476766 Ligands of thrombin
12/19/1995US5476669 Administering a bismuth compound, a first antibiotic from tetracycline and penicillin groups and a second antibiotic which is metronidazole; for preventing recurrence of duodenal ulcer
12/19/1995US5476667 Method for drug formulation and a pharmaceutical composition
12/19/1995US5476654 Preparing tablets by mixing terfenadine with a cross-linked sodium carboxymethyl cellulose and a hydrophilic polymer which gels with water
12/19/1995CA2069869C Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages
12/19/1995CA1337770C Hydrocarbon substituted pyrrolidinones
12/19/1995CA1337767C Indolocarbazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
12/19/1995CA1337766C Derivatives of n-phenylpyrazoles
12/19/1995CA1337764C 1,4-dihydropyridine derivatives and pharmaceutical composition thereof
12/19/1995CA1337763C Staurosporine derivatives with substituted methylamino nitrogen
12/19/1995CA1337760C Antibacterial and antitumor agents ll-e33288e-i and ll-e33288e-br, with processes and intermediates for producing said agents
12/19/1995CA1337754C Red-shifted phthalocyanine and tetrabenztriazaporphyrin reagents
12/18/1995CA2152118A1 Pharmaceutical compositions containing 3,7-diazabicyclo[3,3,1]nonane compounds and use thereof for treating supraventricular arrhythmias
12/18/1995CA2150741A1 Pediatric lipid emulsion
12/15/1995CA2151750A1 Hepatic graft preservative composition and a method for viable preservation of the hepatic graft
12/15/1995CA2151635A1 Antitumoral Compounds
12/14/1995WO1995033840A1 Recombinant viruses, preparation and use thereof in gene therapy
12/14/1995WO1995033761A1 Steroid derivatives for treatment of 5 alpha reductase
12/14/1995WO1995033752A1 Endothelin receptor antagonists
12/14/1995WO1995033751A1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme
12/14/1995WO1995033750A1 Corticotropin releasing factor antagonists
12/14/1995WO1995033748A1 Endothelin receptor antagonists
12/14/1995WO1995033747A1 Novel 1,1-bis(heteroazolyl)alkane derivatives and their use as neuroprotective agents
12/14/1995WO1995033744A1 Tachykinin (nk1) receptor antagonists
12/14/1995WO1995033743A1 Piperazine derivatives as 5ht1a antagonists
12/14/1995WO1995033739A1 New taxoids, preparation thereof and phamaceutical compositions containing them
12/14/1995WO1995033737A1 Taxoids, preparation and pharmaceutical compositions containing them
12/14/1995WO1995033736A1 New taxoids, preparation thereof and pharmaceutical compositions containing them
12/14/1995WO1995033729A1 Serotonin 5-ht1a and dopamin d2 receptor ligands
12/14/1995WO1995033727A1 Substituted pyrazoles having corticotropin-releasing factor (crf) antagonist activity
12/14/1995WO1995033723A1 Phenoxyalkyl substituted piperidines, pyrrolidines, morpholines and thiomorpholines as calcium channel antagonists
12/14/1995WO1995033722A1 Phenoxyalkyl substituted piperidines, pyrrolidines, morpholines and tiomorpholines as calcium channel antagonists
12/14/1995WO1995033721A1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines
12/14/1995WO1995033712A1 Anti-inflammatory compounds
12/14/1995WO1995033709A1 Hydroxylamine derivatives and their use as metalloproteinase inhibiting agents
12/14/1995WO1995033491A1 Biotin compounds for targetting tumors and sites of infection
12/14/1995WO1995033489A1 Stable gel formulation for topical treatment of skin conditions
12/14/1995WO1995033486A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
12/14/1995WO1995033484A1 Method for treating and preventing atherosclerosis
12/14/1995WO1995033478A1 Acylated enol derivatives as prodrugs of elastase inhibitors
12/14/1995WO1995033477A1 Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents
12/14/1995WO1995033473A1 Extracts of stephania tetrandra for inhibition of interleukin-6 production
12/14/1995WO1995033468A1 A pharmaceutical composition comprising oligosaccharides binding to lipoprotein lipase
12/14/1995WO1995033467A2 Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
12/14/1995WO1995033466A1 Pyridylbisphosphonates for use as a therapeutical agent
12/14/1995WO1995033465A1 Pharmaceutical composition for treating peripheral circulation disorder
12/14/1995WO1995033464A2 Retroviral protease inhibitor combinations
12/14/1995WO1995033463A2 Synergistic antibiotic compositions containing a perphyrin and an antibiotic
12/14/1995WO1995033461A1 Anti-inflammatory compounds
12/14/1995WO1995033459A1 Use of a naphthalenesulfonic acid compound for inhibiting retroviral infection
12/14/1995WO1995033457A1 Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
12/14/1995WO1995033456A2 Reducing intraocular pressure using aryloxy- and aryl-acetic acids
12/14/1995WO1995033455A1 Meta substituted arylalkylamines and therapeutic and diagnostic uses thereof
12/14/1995WO1995033454A1 Uterine fibroid treatment
12/14/1995WO1995033453A1 Agonists and antagonists of the nicotinic acetylcholine receptors of insects to control endoparasites
12/14/1995WO1995033451A1 Non-sedating allergy sinus medication
12/14/1995WO1995033443A1 Dermato-cosmetologic composition
12/14/1995WO1995033410A1 Use of dipyridamole and analogs thereof in preventing adhesion formation
1 ... 6959 6960 6961 6962 6963 6964 6965 6966 6967 6968 6969 6970 6971 6972 6973 6974 6975 6976 6977 6978 6979 ... 7860